The role of vascular and angiogenic factors in the development of selective fetal growth restriction in monochorionic multiple pregnancy

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background: Selective fetal growth restriction (sFGR) affects 10-25% of all monochorionic twin pregnancies. If not detected and treated, sFGR is associated with high perinatal mortality and a wide range of neonatal complications. However, currently, due to the introduction of the dynamic fetal monitoring and intrauterine treatments, including fetoscopic laser coagulation of placental vascular anastomoses and the determination of optimal delivery time, it is possible to achieve high survival rates for both fetuses. The main etiological factor of sFGR is placental dysfunction, including morphological and functional changes associated with reduced placental volume, impaired development of arterio-arterial anastomoses, and vascular and angiogenic factors during the formation of an early monochorionic pregnancy. Objective: To investigate the role of vascular endothelial factors in the development of sFGR in monochorionic twin pregnancy. Materials and methods: The study included 51 patients with monochorionic diamniotic twins. Group 1 comprised patients with sFGR (n=31) and Group 2 consisted of patients with uncomplicated monochorionic twin pregnancies (n=20). The study retrospectively analyzed the role of maternal vascular and angiogenic factors at 18-26 weeks’ gestation in the development of sFGR. The analysis also included the evaluation of perinatal outcomes, the course of the early neonatal period, stay in the intensive care unit, and length of hospital stay at the second stage of nursing. Results: The mean age of participants was 31.6 (5.13) years. There were no statistically significant differences in concentrations of vascular and angiogenic factors, pregnancy and early neonatal outcomes. However, high concentrations of maternal VEGF-R1, VEGFC, and HIF-1a were associated with neonatal mortality, and a high concentration of HIF-1a was associated with stillbirth. These findings may be used in clinical practice to predict antenatal and early neonatal loss. Pregnant women with sVEGF-R1 greater than 0.787ng/mL and Ang-2greater than 8255.91 ng/mL were found to have an increased risk of low-birthweight babies. Conclusion: Comparative assessment of vascular and angiogenic factors in sFGR pregnancies offers the opportunity to prevent the progression of this condition by timely fetoscopic intervention, improve perinatal outcomes, and minimize the risks of severe antenatal and neonatal complications.

Full Text

Restricted Access

About the authors

Kristina A. Gladkova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: k_gladkova@oparina4.ru
Ph.D., Senior Researcher at the Fetal Medicine Unit, Institute of Obstetrics, Head of the lst Obstetric Department of Pregnancy Pathology

Viktoriya A. Sakalo

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_sakalo@oparina4.ru
Ph.D., Junior Researcher at the Department of Pregnancy Pathology, Institute of Obstetrics, doctor at the lst Obstetric Department of Pregnancy Pathology

Valentina V. Vtorushina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_vtorushina@oparina4.ru
Ph.D., doctor of laboratory and clinical diagnostics at the Laboratory of Clinical Immunology

Aleksandra A. Piskulina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: a_piskylina@oparina4.ru
clinical resident

Ekaterina R. Frolova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_frolova@oparina4.ru
graduate student at the High Risk Pregnancy Department

Kirill V. Kostyukov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: k_kostyukov@oparina4.ru
Dr. Med. Sci, Senior Researcher at the Fetal Medicine Unit, Institute of Obstetrics, Head of the Department of the Ultrasound and Functional Diagnosis

Zulfiya S. Khodzhaeva

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: z_khodzhaeva@oparina4.ru
Dr. Med. Sci., Professor, Deputy Director of Obstetrics Institute

References

  1. Mackie F.L., Morris R.K., Kilby M.D. The prediction, diagnosis and management of complications in monochorionic twin pregnancies: The OMMIT (Optimal Management of Monochorionic Twins) study. BMC Pregnancy Childbirth. 2017; 17(1): 153. https://dx.doi.org/10.1186/s12884-017-1335-3.
  2. Khalil A., Beune I., Hecher K., Wynia K., Ganzevoort W., Reed K. et al. Consensus definition and essential reporting parameters of selective fetal growth restriction in twin pregnancy: a Delphi procedure. Ultrasound Obstet. Gynecol. 2019; 53(1): 47-54. https://dx.doi.org/10.1002/uog.19013.
  3. Parra-Cordero M., Bennasar M., Martinez J.M., Eixarch E., Torres X., Gratacos E. Cord occlusion in monochorionic twins with early selective intrauterine growth restriction and abnormal umbilical artery Doppler: a consecutive series of 90 cases. Fetal Diagn. Ther. 2016; 39(3): 186-91. https://dx.doi.org/10.1159/000439023.
  4. Chalouhi G.E., Marangoni M.A., Quibel T., Deloison B., Benzina N., Essaoui M. et al. Active management of selective intrauterine growth restriction with abnormal Doppler in monochorionic diamniotic twin pregnancies diagnosed in the second trimester of pregnancy. Prenat. Diagn. 2013; 33(2): 109-15. https://dx.doi.org/10.1002/pd.4031
  5. Townsend R., D'Antonio F., Sileo F.G., Kumbay H., Thilaganathan B., Khalil A. Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction according to management: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2019; 53(1): 36-46. https://dx.doi.org/10.1002/uog.20114.
  6. Wang X., Li L., Yuan P., Zhao Y., Wei Y. Placental characteristics in different types of selective fetal growth restriction in monochorionic diamniotic twins. Acta Obstet. Gynecol. Scand. 2021; 100(9): 1688-93. https://dx.doi.org/10.1111/aogs.14204.
  7. Valsky D.V., Eixarch E., Martinez J.M., Crispi F., Gratacos E. Selective intrauterine growth restriction in monochorionic twins: pathophysiology, diagnostic approach and management dilemmas. Semin. Fetal Neonatal Med. 2010; 15(6): 342-8. https://dx.doi.org/10.1016/j.siny.2010.07.002.
  8. Wu J., He Z., Gao Y., Zhang G., Huang X., Fang Q. Placental NFE2L2 is discordantly activated in monochorionic twins with selective intrauterine growth restriction and possibly regulated by hypoxia. Free Radic. Res. 2017; 51(4): 351-9. https://dx.doi.org/10.1080/10715762.2017.1315113.
  9. Kaufaann P., Mayhew T.M., Charnock-Jones D.S. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta. 2004; 25(2-3): 114-26. https//dx.doi.org/10.1016/j.placenta.2003.10.009.
  10. Lyall F., Greer I.A., Boswell F., Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br. J. Obstet. Gynaecol. 1997; 104(2): 223-8. https://dx.doi.org/10.1111/j.1471-0528.1997.tb11050.x.
  11. Kappou D., Sifakis S., Konstantinidou A., Papantoniou N., Spandidos D.A. Role of the angiopoietin/Tie system in pregnancy (Review). Exp. Ther. Med. 2015; 9(4): 1091-6. https://dx.doi.org/10.3892/etm.2015.2280.
  12. Barut F., Barut A., Gun B.D., Kandemir N.O., Harma M.I., Harma M. et al. Intrauterine growth restriction and placental angiogenesis. Diagn. Pathol. 2010; 5: 24. https://dx.doi.org/10.1186/1746-1596-5-24.
  13. Hunter A., Aitkenhead M., Caldwell C., McCracken G., Wilson D., McClure N. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension. 2000; 36(6): 965-9. https://dx.doi.org/10.1161/01.hyp.36.6.965.
  14. Zhang J., Dunk C.E., Shynlova O., Caniggia I., Lye S.J. TGFb1 suppresses the activation of distinct dNK subpopulations in preeclampsia. EBioMedicine. 2019; 39: 531-9. https://dx.doi.org/10.1016/j.ebiom.2018.12.015.
  15. Basavaraja R., Drum J.N., Sapuleni J., Bibi L., Friedlander G., Kumar S. et al. Downregulated luteolytic pathways in the transcriptome of early pregnancy bovine corpus luteum are mimicked by interferon-tau in vitro. BMC Genomics. 2021; 22(1): 452. https://dx.doi.org/10.1186/s12864-021-07747-3.
  16. Mert I., Oruc A.S., Yuksel S., Cakar E.S., Buyukkagnici U., Karaer A., Danisman N. Role of oxidative stress in preeclampsia and intrauterine growth restriction. J. Obstet. Gynaecol. Res. 2012; 38(4): 658-64. https://dx.doi.org/10.1111/j.1447-0756.2011.01771.x.
  17. Gunatillake T., Yong H.E., Dunk C.E., Keogh R.J., Borg A.J., Cartwright J.E. et al. Homeobox gene TGIF-1 is increased in placental endothelial cells of human fetal growth restriction. Reproduction. 2016; 152(5): 457-65. https://dx.doi.org/10.1530/REP-16-0068.
  18. Ivanov D., Mazzoccoli G., Anderson G., Linkova N., Dyatlova A., Mironova E. et al. Melatonin, its beneficial effects on embryogenesis from mitigating oxidative stress to regulating gene expression. Int. J. Mol. Sci. 2021; 22(11): 5885. https://dx.doi.org/10.3390/ijms22115885.
  19. Anh N.D., Thuong P.H., Sim N.T., Thao T.T.P., Anh L.T.L., Canh T.T.T. et al. Maternal vascular endothelial growth factor receptor and interleukin levels in pregnant women with twin-twin transfusion syndrome. Int. J. Med. Sci. 2021; 18(14): 3206-13. https://dx.doi.org/10.7150/ijms.61014.
  20. Olaya-C.M., Garrido M., Hernandez-Losa J., Sese M., Ayala-Ramirez P., Somoza R. et al. The umbilical cord, preeclampsia and the VEGF family. Int. J. Womens Health. 2018; 10: 783-95. https://dx.doi.org/10.2147/IJWH.S174734.
  21. He Y., Smith S.K., Day K.A., Clark D.E., Licence D.R., Charnock-Jones D.S. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol. Endocrinol. 1999; 13(4): 537-45. https://dx.doi.org/10.1210/mend.13.4.0265.
  22. Tammela T., Zarkada G., Nurmi H., Jakobsson L., Heinolainen K., Tvorogov D. et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 2011; 13(10): 1202-13. https://dx.doi.org/10.1038/ncb2331.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies